Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line

Scientific Reports

Volumn 3, Issue , 2013, Pages

  He, Xuan ^a   Mishchuk, Darya O ^a   Shah, Jigna ^a   Weimer, Bart C ^a   Slupsky, Carolyn M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID;

ADENOCARCINOMA; CACO 2 CELL LINE; CITRIC ACID CYCLE; COCULTURE; COLORECTAL TUMOR; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

ADENOCARCINOMA; CACO-2 CELLS; CELL LINE, TUMOR; CITRIC ACID CYCLE; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; HUMANS; LACTIC ACID;

EID: 84890167496     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03416     Document Type: Article

References (47)

1. Cucchiara, S., Iebba, V., Conte, M. P. & Schippa, S. The microbiota in inflammatory bowel disease in different age groups. Dig. Dis. 27, 252-258 (2009).
2. Tiihonen, K., Ouwehand, A. C. & Rautonen, N. Human intestinal microbiota and healthy ageing. Ageing. Res. Rev. 9, 107-116 (2010).
3. Wu, G. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 334, 105-108 (2011).
4. He, X., Marco, M. & Slupsky, C. Emerging Aspects of Food and Nutrition on Gut Microbiota. J. Agric. Food Chem. DOI: 10.1021/jf4029046 (2013).
5. Musso, G., Gambino, R. & Cassader, M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 62, 361-380 (2011).
6. Tilg, H. & Kaser, A. Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121, 2126-2132 (2011).
7. Turnbaugh, P. & Gordon, J. The core gut microbiome, energy balance and obesity. J. Physiol. 587, 4153-4158 (2009).
8. Martin, F. P. J. et al.Atop-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 3, 112 (2007).
9. Cummings, J. H. & Macfarlane, G. T. Role of intestinal bacteria in nutrient metabolism. JPEN J. Parenter. Enteral. Nutr. 21, 357-365 (1997).
10. Holmes, E., Li, J., Athanasiou, T.,Ashrafian,H. & Nicholson, J. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trend. Microbiol. 19, 349-359 (2011).
11. Cani, P. & Delzenne, N. The gut microbiome as therapeutic target. Pharmacol. Ther. 130, 202-212 (2011).
12. Fanaro, S., Chierici, R., Guerrini, P. & Vigi, V. Intestinal microflora in early infancy: composition and development. Acta. Paediatr. Suppl. 91, 48-55 (2003). (Pubitemid 37239252)
13. Vajro, P., Paolella, G. & Fasano, A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J. Pediatr. Gastroenterol. Nutr. 56, 461-468 (2013).
14. Barnich, N. et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 117, 1566-1574 (2007).
15. Rolhion, N. & Darfeuille-Michaud, A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm. Bowel Dis. 13, 1277-1283 (2007). (Pubitemid 47597778)
16. Barnich, N. & Darfeuille-Michaud, A. Adherent-invasive Escherichia coli and Crohn's disease. Curr. Opin. Gastroenterol. 23, 16-20 (2007). (Pubitemid 44875904)
17. Bronowski, C. et al. A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. Microbiology. 154, 571-583 (2008). (Pubitemid 351292311)
18. Santacruz, A. et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring). 17, 1906-1915 (2009).
19. Santacruz, A. et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104, 83-92 (2010).
20. Tedelind, S., Westberg, F., Kjerrulf, M. & Vidal, A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13, 2826-2832 (2007). (Pubitemid 47007897)
21. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature. 410, 37-40 (2001). (Pubitemid 32225829)
22. Chen, Z. et al. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. Cancer Lett. 188, 127-140 (2002). (Pubitemid 35299421)
23. Hernandez-Saavedra, D., Zhou, H. & McCord, J. M. Anti-inflammatory properties of a chimeric recombinant superoxide dismutase: SOD2/3. Biomed. Pharmacother. 59, 204-208 (2005). (Pubitemid 40603334)
24. Sydora, B. et al. An imbalance in mucosal cytokine profile causes transient intestinal inflammation following an animal's first exposure to faecal bacteria and antigens. Clin. Exp. Immunol. 161, 187-196 (2010).
25. Fukushima, K. et al. Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice. Scand. J. Gastroenterol. 38, 626-634 (2003). (Pubitemid 36724042)
26. Jarvis, K. et al. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. U. S. A. 92, 7996-8000 (1995).
27. Nataro, J. P. & Kaper, J. B. Diarrheagenic escherichia coli. Clin. Microbiol. Rev. 11, 142-201 (1998). (Pubitemid 28046019)
28. Wolfe, A. The acetate switch. Microbiol. Mol. Biol. Rev. 69, 12-50 (2005). (Pubitemid 40360710)
29. Alam, K. & Clark, D. Anaerobic fermentation balance of Escherichia coli as observed by in vivo nuclear magnetic resonance spectroscopy. J. Bacteriol. 171, 6213-6217 (1989). (Pubitemid 19266945)
30. Ganesan, B. & Weimer, B. C. Role of aminotransferase IlvE in production of branched-chain fatty acids by Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 70, 638-641 (2004). (Pubitemid 38090263)
31. Ganesan, B., Stuart, M. R. & Weimer, B. C. Carbohydrate starvation causes a metabolically active but nonculturable state in Lactococcus lactis. Appl. Environ. Microbiol. 73, 2498-2512 (2007). (Pubitemid 46668742)
32. Ganesan, B., Seefeldt, K. & Weimer, B. C. Fatty acid production from amino acids and alpha-keto acids by Brevibacterium linens BL2. Appl. Environ. Microbiol. 70, 6385-6393 (2004). (Pubitemid 39518541)
33. Ganesan, B., Seefeldt, K., Koka, R. C., Dias, B. & Weimer, B. C. Monocarboxylic acid production by lactococci and lactobacilli. Int. Dairy J. 14, 237-246 (2004). (Pubitemid 38203939)
34. Ganesan, B., Dobrowolski, P. & Weimer, B. C. Identification of the leucine-to-2- methylbutyric acid catabolic pathway of Lactococcus lactis. Appl. Environ. Microbiol. 72, 4264-4273 (2006). (Pubitemid 43894896)
35. Reeds, P. J. & Burrin, D. G. Glutamine and the bowel. J. Nutr. 131, 2505S-2508S; discussion 2523S-2504S (2001). (Pubitemid 32847000)
36. Brand, K. & Hermfisse, U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11, 388-395 (1997). (Pubitemid 27193945)
37. Kennedy, K. M. & Dewhirst, M. W. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol. 6, 127-148 (2010).
38. Trabold, O. et al. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen. 11, 504-509 (2003). (Pubitemid 37467735)
39. Dawson, A. G. Oxidation of cytosolic NADH formed during aerobic metabolism in mammalian cells. Trends. Biochem. Sci. 4, 171-176 (1979). (Pubitemid 9227381)
40. Naik, E. & Dixit, V. M. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 208, 417-420 (2011).
41. Rezaie, A., Parker, R. D. & Abdollahi, M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 52 (2007).
42. Ullman, T. A. & Itzkowitz, S. H. Intestinal inflammation and cancer. Gastroenterology. 140, 1807-1816 (2011).
43. McGrath, B. M., Greenshaw, A. J., McKay, R., Slupsky, C. M. & Silverstone, P. H. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T. Neuroreport. 17, 1323-1326 (2006). (Pubitemid 44337075)
44. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome. Biol. 5, R80 (2004).
45. Irizarry, R. A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic. Acids. Res. 31, e15 (2003).
46. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98, 5116-5121 (2001). (Pubitemid 32397092)
47. Weljie, A. M., Newton, J., Mercier, P., Carlson, E. & Slupsky, C. M. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78, 4430-4442 (2006).